Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board remands the claim for a new VA medical opinion to address the Veteran's skin condition and its potential relation to service, including herbicide exposure.

The Board granted a 60 percent rating for psoriasis from February 24, 2020 to April 1, 2025.

The Board denied service connection for urinary tract infections, herpes simplex virus, and a compensable disability rating for bilateral tinea pedis.

The Board remands the issues of entitlement to a disability evaluation in excess of 10 percent for cirrhosis of the liver and status post cholecystectomy, a compensable disability evaluation for surgical scars associated with cirrhosis of the liver and status post cholecystectomy, and a compensable disability evaluation, including whether the reduction from 10 percent to 0 percent effective March 1, 2015, was proper, for service-connected pseudofolliculitis barbae.

The Board revised the November 2007 rating decision to assign a 30 percent disability rating for migraine headaches due to CUE, but denied the motion to revise the same decision to assign a 10 percent disability rating for eczematous dermatitis.

The Board granted readjudication of the claims for service connection for lupus, an acquired psychiatric disorder, a skin disorder, and a respiratory condition due to new and material evidence being submitted since the last final denial.

The Board granted service connection for skin cancer and assigned a 40 percent disability rating for left shoulder strain, while denying service connection for an acquired psychiatric disorder, flatfoot bilateral, erectile dysfunction, and other conditions.

The Board denied the veteran's claims for a compensable disability rating for eczema, top of right index finger and warts with onychomycosis of the right great toe and bilateral 5th toes.

The Board remands the claims for further development and to correct pre-decisional duty-to-assist errors.

The Board remands the claims for service connection for eczema, rhinitis, and obstructive sleep apnea (OSA) to correct duty to assist errors that occurred prior to the decision on appeal.

The Board denied service connection for right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, tongue cramps, and skin disorders as the evidence did not support a finding of current disability or nexus to in-service toxic exposures.

The Board denied service connection for bilateral hearing loss and remanded the claims for acne, scarring, lower back pain, left knee condition, right knee condition, and bronchitis for further development.

The Board granted initial 10 percent ratings for right and left lower extremity deep peroneal neuritis effective December 18, 2024, but denied higher ratings for diabetic peripheral neuropathy and dermatitis.

The Board remands the claim for service connection of bilateral tinea pedis due to an inadequate VA examination and to obtain a new opinion regarding the nature and etiology of the condition.

The Veteran's unspecified depressive disorder precluded him from securing and maintaining substantially gainful employment, leading to the grant of a TDIU rating.

The Board denied the Veteran's claims for an initial compensable rating for pseudofolliculitis barbae, service connection for hypertension and bilateral flat feet.

The appeal for increased initial disability ratings was dismissed due to the Veteran not timely filing a Notice of Disagreement within one year of the rating decisions.

The Board remands the matter for further review to clarify the Veteran's medication use and determine an appropriate disability rating.

The Board granted service connection for urinary frequency and acne, as well as a total disability rating due to individual unemployability.

The Board denied an earlier effective date for service connection of headaches disorder and tinea versicolor disorder, as the evidence did not support a claim prior to June 28, 2022.